Cystatin C as a Risk Factor for Outcomes in Chronic Kidney DiseaseVandana Menon, Mark J. Sarnak, Xuelei Wang et al.|Annals of Internal Medicine|2007Cited by 203
A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1αXuelei Wang, Bin Hong|EBioMedicine|2020Cited by 50